US biopharma: 180 new diabetes drugs now in R&D

21st February 2014

US biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people worldwide who suffer from diabetes, says a new industry report.

The medicines in development are all either in clinical trials or under review by the Food and Drug Administration (FDA), and they include 30 potential new treatments for type 1 diabetes, 100 for type 2 and 52 for diabetes-related conditions, according to the report, from the Pharmaceutical Research and Manufacturers of America (PhRMA).

Read more at source www.pharmatimes.com


Leave a Reply

Your email address will not be published.

+ 77 = 85

« back to posts